National Health (Pharmaceutical Benefits—Early Supply) Specification 2026
5Definitions
Start here
Get a plain-English read of 5
Turn the raw legal text into a practical explanation grounded in National Health (Pharmaceutical Benefits—Early Supply) Specification 2026.
5 Definitions
(1) In this instrument:
Act means the National Health Act 1953.
determined maximum quantity or number of units, for a pharmaceutical item in a pharmaceutical benefit, means a quantity or number of units determined under paragraph 85A(2)(a) of the Act as the maximum quantity or number of units of the pharmaceutical item that may, in one prescription, be directed to be supplied on any one occasion determined.
Note: A maximum quantity or number of units can be determined in relation to prescriptions directing the supply of the pharmaceutical item for all purposes, or for particular purposes: see paragraph 85A(2)(a) of the Act.
determined maximum number of repeats, for a pharmaceutical benefit, means the number determined under paragraph 85A(2)(b) of the Act as a maximum number of occasions on which the supply of the pharmaceutical benefit may, in one prescription, be directed to be repeated.
Note: A maximum number of repeats can be determined in relation to prescriptions directing the supply of the pharmaceutical benefit for all purposes, or for particular purposes: see paragraph 85A(2)(b) of the Act.
g means gram.
I.U. means international unit.
listed drug has the meaning given by section 84 of the Act.
mg means milligram.
mL means millilitre.
pharmaceutical benefit has the meaning given by section 84 of the Act.
pharmaceutical item has the meaning given by section 84AB of the Act.
prescriber bag provisions has the meaning given by section 84 of the Act.
purposes code has the same meaning as in the National Health (Listing of Pharmaceutical Benefits) Instrument 2024.
relevant previous supply, for a pharmaceutical benefit, means the most recent previous supply to a person of:
(a) the same pharmaceutical benefit; or
(b) another pharmaceutical benefit that has the same pharmaceutical item as the pharmaceutical benefit; or
(c) another pharmaceutical benefit that is Schedule equivalent to the pharmaceutical benefit.
relevant purpose, for a pharmaceutical benefit, means a purpose, mentioned in Schedule 4 of the National Health (Listing of Pharmaceutical Benefits) Instrument 2024 for a purposes code specified in Schedule 1 of that instrument for the pharmaceutical benefit, that includes the phrase “The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient”.
Schedule equivalent has the meaning given by section 84AJ of the Act.
(2) A reference in this instrument to supply on the basis of a prescription includes reference to supply on the basis of a repeat authorisation or deferred supply authorisation.